Form 4: Gilead Sciences Executive Deborah H. Telman Reports Changes in Beneficial Ownership
SEC Form 4 Filing
EVP Deborah H. Telman of Gilead Sciences reports transactions involving common stock and restricted stock units.
Summary
- On April 25, 2024, Deborah H. Telman, EVP, Corporate Affairs & GC of Gilead Sciences, Inc., reported changes in beneficial ownership of the company's securities.
- Telman disposed of 515 shares of common stock upon the vesting of restricted stock units.
- A further 158 shares were disposed of to cover tax obligations at a price of $65.27 per share.
- Following these transactions, Telman directly owns 14,114 shares of Gilead Sciences common stock and 39,568 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral regulatory filing detailing stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is a common practice in publicly traded companies to ensure transparency and compliance with securities regulations.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders as they represent routine executive stock activity.
Key Dates
| Date | Description |
|---|---|
| 04/25/2024 | Date of transaction involving common stock and restricted stock units. |
| 04/26/2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.